Extraintestinal manifestations in inflammatory bowel disease

被引:238
作者
Danese, Silvio [1 ]
Semeraro, Stefano [1 ]
Papa, Alfredo [1 ]
Roberto, Italia [1 ]
Scaldaferri, Franco [1 ]
Fedeli, Giuseppe [1 ]
Gasbarrini, Giovanni [1 ]
Gasbarrini, Antonio [1 ]
机构
[1] Catholic Univ Sch Med, Dept Internal Med, I-00168 Rome, Italy
关键词
Crohn's disease; Ulcerative colitis; Inflammatory bowel disease;
D O I
10.3748/wjg.v11.i46.7227
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel diseases (IBD) can be really considered to be systemic diseases since they are often associated with extraintestinal manifestations, complications, and other autoimmune disorders. Indeed, physicians who care for patients with ulcerative colitis and Crohn's disease, the two major forms of IBD, face a new clinical challenge every day, worsened by the very frequent rate of extraintestinal complications. The goal of this review is to provide an overview and an update on the extraintestinal complications occurring in IBD. Indeed, this paper highlights how virtually almost every organ system can be involved, principally eyes, skin, joints, kidneys, liver and biliary tracts, and vasculature (or vascular system) are the most common sites of systemic IBD and their involvement is dependent on different mechanisms. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:7227 / 7236
页数:10
相关论文
共 118 条
  • [71] Okolicsanyi L, 1996, EUR J GASTROEN HEPAT, V8, P685
  • [72] Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications?
    Oldenburg, B
    Fijnheer, R
    van der Griend, R
    vanBerge-Henegouwen, GP
    Koningsberger, JC
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) : 2825 - 2830
  • [73] Risk factors for thromboembolic complications in inflammatory bowel disease: The role of hyperhomocysteinaemia
    Oldenburg, B
    Van Tuyl, BAC
    van der Griend, R
    Fijnheer, R
    Henegouwen, GPV
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (02) : 235 - 240
  • [74] Review article: iron and inflammatory bowel disease.
    Oldenburg, B
    Koningsberger, JC
    Henegouwen, GPV
    Van Asbeck, BS
    Marx, JJM
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (04) : 429 - 438
  • [75] Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes
    Orchard, TR
    Chua, CN
    Ahmad, T
    Cheng, H
    Welsh, KI
    Jewell, DP
    [J]. GASTROENTEROLOGY, 2002, 123 (03) : 714 - 718
  • [76] Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history
    Orchard, TR
    Wordsworth, BP
    Jewell, DP
    [J]. GUT, 1998, 42 (03) : 387 - 391
  • [77] Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis
    Orii, S
    Chiba, T
    Nakadate, I
    Fujiwara, T
    Ito, N
    Ishii, M
    Oana, S
    Chida, T
    Kudara, N
    Terui, T
    Yamaguchi, T
    Suzuki, K
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (03) : 251 - 254
  • [78] Review article: Inherited thrombophilia in inflammatory bowel disease
    Papa, A
    Danese, S
    Grillo, A
    Gasbarrini, G
    Gasbarrini, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (06) : 1247 - 1251
  • [79] Papa A, 2001, AM J GASTROENTEROL, V96, P1301
  • [80] Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells:: improvement following anti-tumor necrosis factor-α antibody therapy
    Papadaki, HA
    Kritikos, HD
    Valatas, V
    Boumpas, DT
    Eliopoulos, GD
    [J]. BLOOD, 2002, 100 (02) : 474 - 482